NEW YORK (GenomeWeb) — Cancer Genetics today reported a 7 percent increase in its second quarter revenues driven by its biopharma and discovery services units.
For the three-month period ended June 30, CGI's revenues rose to $7.0 million from $6.6 million in the same quarter last year.